Subscribe To
Verona pharma to present additional analyses of positive phase 3 enhance studies in copd at chest 2023
PDUFA Target Action Date of June 26, 2024 Pooled analysis and subgroup data further support potential of ensifentrine, an investigational, novel, se...
October 3, 2023, 2:00 am
Newamsterdam pharma's pioneering pulse on alzheimer's breakthroughs
New clinical data shows the potential of obicetrapib in treating early Alzheimer's disease in patients with the ApoE4 mutation. The Phase IIa trial de...
October 2, 2023, 9:26 pm
Roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd
Basel, 02 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new data for OCREVUS® (ocrelizumab) and investigational Bruton's tyrosine ki...
October 2, 2023, 1:00 am
3 stocks you can keep forever
Numerous studies have concluded that timing the market doesn't work. Costco's enormous membership base ...
September 30, 2023, 6:15 am
Karuna (krtx) submits nda filing to fda for schizophrenia drug
If approved, Karuna's (KRTX) KarXT will be the first new mechanism of action to treat schizophrenia in several decades. Data from three clinical ...
September 29, 2023, 2:17 pm
Incyte to present multiple studies from dermatology portfolio at 2023 european academy of dermatology and venereology (eadv) congress
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte to Present Multiple studies from Dermatology Portfo...
September 29, 2023, 1:43 pm
Forte minerals' pucarini gold project secures environmental impact statement approval
Forte Minerals Corp. (CSE:CUAU, OTCQB:FOMNF) said its Environmental Impact Statement (DIA) for its 100%-owned Pucarini gold project in Southern Peru h...
September 29, 2023, 9:43 am
Usd/jpy outlook: psychological 150 barrier under increased pressure
USD/JPY edged lower from new multi-month high in early Thursday’s trading, as bulls approached psychological 150 barrier and started to face headwin...
September 28, 2023, 9:14 am
Nektar (nktr), cellular biomedicine join for lung cancer studies
Nektar (NKTR) enters into a deal with Cellular Biomedicine Group to develop NKTR-255 in combination with C-TIL05 to treat advanced NSCLC....
September 28, 2023, 9:01 am
Africa oil announces positive test results from namibian operations
Africa Oil Corp (TSX:AOI) has announced that investee company Impact Oil and Gas Limited reported positive drill stem test (DST) results for the Venus...
September 28, 2023, 8:17 am
Medicinova announces results of studies under barda contract to develop mn 166 (ibudilast) as a medical countermeasure against chlorine gas-induced lung injury
LA JOLLA, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) a...
September 27, 2023, 11:00 pm
Esso ditches rigs to reefs oil dumping
In Melbourne, an Esso spokesperson suggested that following the uptick in good environmental news, its retired oil platforms would be removed — incl...
September 27, 2023, 11:36 am
Eur/usd: bears may take a breather before larger downtrend resumes
EURUSD hit new multi-month low early Wednesday and showing scope for further weakness after break of pivotal Fibo support at 1.0611 (38.2% of 0.9535/1...
September 27, 2023, 8:39 am
Merck (mrk), eisai combo therapy fail two lung cancer studies
Data from both late-stage studies evaluating Merck's (MRK) Keytruda and Eisai's Lenvima combination in ...
September 25, 2023, 1:32 pm
Morphic to present positive emerald-1 phase 2a data for morf-057 in patients with moderate to severe ulcerative colitis in abstract for uegw 2023
-Orally administered MORF-057 achieved primary endpoint and demonstrates clinically meaningful improvements across secondary and exploratory measures-...
September 22, 2023, 9:30 pm
Envirometal initiates $1m private placement to boost sustainable precious metal extraction technologies
EnviroMetal Technologies (CSE:ETI, OTCQB:EVLLF) has announced a non-brokered private placement to raise up to $1 million to advance its precious metal...
September 21, 2023, 9:27 am
Why shares of ars pharmaceuticals are plummeting on wednesday
ARS Pharmaceutical is seeking the approval of Neffy, a nasal spray version of epinephrine. The FDA is seeking additional dosing ...
September 20, 2023, 12:42 pm
Ars pharmaceuticals stock falls toward record selloff after fda issues surprise crl, requesting additional studies
Sharesof ARS Pharmaceuticals Inc. SPRY plunged 46.9% toward a 15-month low in premarket trading Wednesday, after the biopharmaceutical company said th...
September 20, 2023, 6:21 am
Smart money rotations: 3 top ranked utilities stocks to get defensive
Based on seasonality studies, the stock market is entering the weakest period of the year. The second h...
September 15, 2023, 3:02 pm
Moderna (mrna) receives chmp nod for updated covid vaccine
Clinical data from studies on Moderna's (MRNA) updated COVID vaccine shows improved antibody responses ...
September 15, 2023, 11:17 am